RECRUITMENT HAS NOW CLOSED – INIT II is now in follow up phase and we are no longer conducting screening blood tests.

The Type 1 Diabetes Prevention Trial, also known as the Intranasal Insulin Trial (INIT II), is part of a coordinated global effort to develop a vaccine for type 1 diabetes. The trial, which began in 2006, is jointly funded by the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes Research Foundation >> Find out more

  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more
  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more
  • RECRUITMENT HAS NOW CLOSED. If you are already registered for the Type 1 Diabetes Prevention Trial, you are still ...
    >> Read more
  • RECRUITMENT HAS NOW CLOSED. If you are already registered for the Type 1 Diabetes Prevention Trial, you are still ...
    >> Read more
  • Congratulations to Professor Peter Colman on receiving the Chairman's Lifetime Achievement Award from Lord ...
    >> Read more
  • Are you Eligible?

    RECRUITMENT HAS NOW CLOSED.  If you are already registered for the Type 1 Diabetes Prevention Trial, you are still eligible for a screening blood test.

    Anyone who is aged between 4 and 30 and has type
    >> Find out more

  • Spread the Word

    Click the icons below to email a friend or spread the word via Facebook or Twitter. The green ShareThis icon also lets you tell your friends via LinkedIn, Google and Yahoo! So, no excuses!

  • Learn About Diabetes

    Type 1 diabetes, previously known as juvenile or early-onset diabetes, is an autoimmune disease in which the body's immune system destroys the cells that produce insulin. Located in the pancreas, these cells are called beta cells. Although less co
    >> Find out more
  • Resources

    Help us spread the word! Download the Type 1 Diabetes Prevention Trial resources here and start telling you patients, colleagues, family and friends about the trial today.
    >> Find out more